Safety in switching from innovator Adalimumab to its biosimilar and from biosimilar to biosimilar. Universitas Scientiarum, [S. l.], p. S24, 2025. DOI: 10.11144/Javeriana.SCSI30.sisf. Disponível em: https://revistas.javeriana.edu.co/index.php/scientarium/article/view/41559. Acesso em: 10 nov. 2025.